Aimee A Metzner

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 11

Top Topics

Systematic Review

Men Who Have Sex With Men

Top Venues

Infectious diseases and therapy

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy 13 (4) (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy 13 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy 13 (4) (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy 13 (4) (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics 42 (4) (2024)
Anita J Brogan, Ashley E Davis, Claire E Mellott, Jeremy Fraysse, Aimee A Metzner, Alan K Oglesby
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States. PharmacoEconomics (2024)
Paul Benson, Jennifer Kuretski, Cynthia Donovan, Gavin Harper, Deanna Merrill, Aimee A Metzner, Katie Mycock, Hannah Wallis, Andrew P Brogan, Jimena Patarroyo, Alan Oglesby
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses. Infectious diseases and therapy 13 (4) (2024)